Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a potent class of drugs in the management of type 2 diabetes mellitus. These agents simulate the actions of naturally occurring GLP-1, stimulating insulin secretion and reducing glucagon release. Recent studies have yielded a broad range of novel GLP-1 receptor agonists with modified

In the realm of peptide synthesis, achieving high yield and purity is paramount. A multitude of factors affect manufacturing processes, and optimizing these variables is crucial for success. Efficient purification techniques, coupled with meticulous preparation conditions, are key to minimizing impurities and maximizing product yield. Furthermore,